Apply for Cancer Control Grants

The Division of Cancer Control and Population Sciences funds a large portfolio of grants and contracts. The portfolio currently includes approximately 800 grants valued at nearly $450 million. Here we provide a listing of funding opportunities that are currently accepting applications. Please visit this page regularly as new funding opportunities are added upon approval by NCI.

For information on the portfolio of over 800 grants, please go to Research Portfolios section of this website.


Filters

Show/Hide Filters
Research Categories
Type of Funding
Activity Code
Type of Research
Title Announcement # / Mechanism(s) Activity Code Clinical Research Expiration Date Program Contact Research Categories Type of Research
Modular R01s in Cancer Control and Population Sciences PAR-18-869 Parent Announcement R01 Clinical Trial Optional March 9, 2021   Parent and Omnibus Funding Announcements Clinical Trials
Cancer Prevention and Control Clinical Trials Grant Program PAR-18-559 Parent Announcement R01 Clinical Trial Required January 8, 2021   Parent and Omnibus Funding Announcements Clinical Trials
Academic Research Enhancement Award PA-18-343 Parent Announcement R15 Clinical Trial Required January 8, 2021   Parent and Omnibus Funding Announcements Clinical Trials
NIH Research Project Grant PA-18-484 Parent Announcement Parent R01 Clinical Trial Not Allowed January 8, 2021   Parent and Omnibus Funding Announcements Clinical Trials
NCI Small Grants Program for Cancer Research PAR-18-021 Parent Announcement R03 Clinical Trial Optional January 8, 2020   Parent and Omnibus Funding Announcements Clinical Trials
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-893 R01 Clinical Trial Optional September 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Cancer Survivorship Clinical Trials
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-892 R21 Clinical Trial Optional September 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Cancer Survivorship Clinical Trials
HLA and KIR Region Genomics in Immune-Mediated Diseases RFA-AI-19-041 U01 Clinical Trial Not Allowed September 5, 2019 Danielle Carrick
240-276-6749
carrick@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Exploratory Grants in Cancer Epidemiology and Genomics Research PAR-19-277 R21 Clinical Trial Optional October 9, 2021 Mukesh Verma
240-276-6889
vermam@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-112 R01 Clinical Trial Optional January 8, 2022 Nonniekaye Shelburne
240-276-6897
nshelburne@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-111 R21 Clinical Trial Optional January 8, 2022 Nonniekaye Shelburne
240-276-6897
nshelburne@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Diet and Physical Activity Assessment Methodology PAR-18-857 R21
Clinical Trial Not Allowed September 8, 2021 Amy Subar
301-594-0831
subara@mail.nih.gov

Richard Troiano
240-276-6916
troianor@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Diet and Physical Activity Assessment Methodology PA-18-856 R01 Clinical Trial Not Allowed September 08, 2021 Amy Subar
301-594-0831
subara@mail.nih.gov

Richard Troiano
240-276-6916
troianor@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression Announcement Numbers PA-18-738 R01 Clinical Trial Optional May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression Announcement Numbers PA-18-739 R21 Clinical Trial Optional May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility PA-18-677 R01 Clinical Trial Not Allowed May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility PA-18-678 R21 Clinical Trial Not Allowed May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Early-life Factors and Cancer Development Later in Life PA-18-531 R03 Clinical Trial Not Allowed January 8, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Early-life Factors and Cancer Development Later in Life PA-18-529 R01 Clinical Trial Not Allowed January 8, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Early-life Factors and Cancer Development Later in Life PA-18-532 R21 Clinical Trial Not Allowed January 8, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PA-17-444 R01   September 8, 2020 Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors RFA-CA-19-033 U01 Clinical Trial Optional January 4, 2020 Sandra Mitchell
240-276-6929
mitchlls@mail.nih.gov

Danielle Daee
240-276-5744
daeed@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PA-17-446 R21   September 8, 2020 Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PA-17-445 R03   September 8, 2020 Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov
Epidemiology and Genomics Research Not Clinical Trials
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research PAR-17-279 R01   May 8, 2020 Rebecca Liddell Huppi
301-496-4995
liddellr@exchange.nih.gov

Mukesh Verma
240-276-6889
vermam@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research PA-17-278 R21   May 8, 2020 Rebecca Liddell Huppi
301-496-4995
liddellr@exchange.nih.gov

Mukesh Verma
240-276-6889
vermam@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PA-17-239 R01   May 8, 2020 Melissa Rotunno
240-276-7245
rotunnom@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PA-17-243 R21   May 8, 2020 Melissa Rotunno
240-276-7245
rotunnom@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts PAR-17-233 U01   May 8, 2020 Joanne Elena
240-276-6818
joanne.elena@nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Genomic Community Resources PAR-17-273 U24   January 26, 2020 Leah Mechanic
240-276-6847
mechanil@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations PA-17-041 R01   January 8, 2020 Tram Lam
240-276-6967
lamt@mail.nih.gov

Damali Martin
240-276-6746
martinda@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations PA-17-042 R21   January 8, 2020 Tram Lam
240-276-6967
lamt@mail.nih.gov

Damali Martin
240-276-6746
martinda@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Clinical and Epidemiological Research on Chronic Disease in the Caribbean PAR-17-470 R01   November 16, 2019 Damali Martin
240-276-6746
martinda@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers PA-16-426 R01   September 8, 2019 Elizabeth Read-Connole
240-276-6226 
bconnole@mail.nih.gov

Mukesh Verma
240-276-6889
vermam@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers PA-16-425 R21   September 8, 2019 Elizabeth Read-Connole
240-276-6226 
bconnole@mail.nih.gov

Mukesh Verma
240-276-6889
vermam@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Secondary Analyses of Alcohol and Chronic Disease PA-16-395
R01
  September 8, 2019 Somdat Mahabir
240-276-6941
mahabir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Secondary Analyses of Alcohol and Chronic Disease PA-16-394
R03   September 8, 2019 Somdat Mahabir
240-276-6941
mahabir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses PAR-19-136 R01 Clinical Trial Optional January 8, 2022 Ashley Wilder Smith
240-276-6714
smithas@mail.nih.gov
Healthcare Delivery Research Clinical Trials
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses PAR-19-153 R21 Clinical Trial Optional January 8, 2022 Ashley Wilder Smith
240-276-6714
smithas@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations PA-18-932 R01 Clinical Trial Optional January 8, 2022 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer PA-18-492 R21 Clinical Trial Optional May 8, 2021 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Healthcare Delivery Research Clinical Trials
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer PA-18-493 R01 Clinical Trial Optional May 8, 2021 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Healthcare Delivery Research Clinical Trials
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests PA-17-495 R01 Clinical Trial Optional January 8, 2021 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults PA-18-005 R01 Clinical Trial Optional January 8, 2020 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults PA-18-015  R21 Clinical Trial Optional   January 8, 2020 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers PA-18-149 R01 Clinical Trial Optional January 8, 2020 Michelle Mollica
240-276-7621
mollicama@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers PA-18-167 R21 Clinical Trial Optional January 8, 2020 Michelle Mollica
240-276-7621
mollicama@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Methodology and Measurement in the Behavioral and Social Sciences PAR-18-352 R01 Clinical Trial Optional September 8, 2019 Sandra Mitchell
240-276-6929
mitchellsa@cc.nih.gov
Healthcare Delivery Research Clinical Trials
Methodology and Measurement in the Behavioral and Social Sciences PAR-18-378 R21 Clinical Trial Optional September 8, 2019 Sandra Mitchell
240-276-6929
mitchellsa@cc.nih.gov
Healthcare Delivery Research Clinical Trials
Research Infrastructure Development for Interdisciplinary Aging Studies PAR-16-367 R21/R33   September 8, 2019 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Not Clinical Trials
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies PAR-16-368 R33   September 8, 2019 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Not Clinical Trials
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-18-008 R01 Clinical Trial Optional July 6, 2019 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-16-337 R03   July 17, 2019 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
Healthcare Delivery Research Not Clinical Trials
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-18-019 R21 Clinical Trial Optional July 17, 2019 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care RFA-CA-19-035 R01 Clinical Trial Required June 29, 2019 Michelle Mollica
240-276-7621
mollicama@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors PAR-19-018 R01 Clinical Trial Not Allowed March 5, 2021 Damali Martin
240-276-6746
martinda@mail.nih.gov
Health Disparities Not Clinical Trials
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors PAR-19-019 R21 Clinical Trial Not Allowed March 5, 2021 Damali Martin
240-276-6746
martinda@mail.nih.gov
Health Disparities Not Clinical Trials
Academic Research Enhancement Award PA-18-504 Parent R15   January 8, 2021 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Not Clinical Trials
Administrative Supplements to Support Cancer Disparity Collaborative Research PA-18-842   Clinical Trial Optional September 11, 2020 Damali Martin
240-276-6746
martinda@mail.nih.gov
Health Disparities Clinical Trials
Intervention Research to Improve Native American Health PAR-17-496 R01   May 15, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Not Clinical Trials
Research to Improve Native American Health (R21 Clinical Trials Optional) PAR-17-464 R21   May 15, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Not Clinical Trials
Addressing Health Disparities through Effective Interventions Among Immigrant Populations PA-18-284 R01 Clinical Trial Optional January 8, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Clinical Trials
Addressing Health Disparities through Effective Interventions Among Immigrant Populations PA-18-285 R21 Clinical Trial Optional January 8, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Clinical Trials
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers PAR-17-483 R21   December 5, 2019 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Not Clinical Trials
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers PAR-17-484 R01   December 5, 2019 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Not Clinical Trials
Surgical Disparities Research PAR-18-288 R01 Clinical Trial Optional June 8, 2019 Brenda A. Adjei
240-276-6185
adjeiba@mail.nih.gov
Health Disparities Clinical Trials
Surgical Disparities Research PAR-18-289 R21 Clinical Trial Optional June 8, 2019 Brenda A. Adjei
240-276-6185
adjeiba@mail.nih.gov
Health Disparities Clinical Trials
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-274 R01 Clinical Trial Optional May 8, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
Implementation Science Clinical Trials
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-275 R21 Clinical Trial Optional May 8, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
Implementation Science Clinical Trials
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-276 R03   May 8, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
Implementation Science Not Clinical Trials
Integration of Individual Residential Histories into Cancer Research PA-17-298 R01   September 8, 2020 Zaria Tatalovich
240-276-6976
tatalovichzp@mail.nih.gov
Surveillance Research Not Clinical Trials
Integration of Individual Residential Histories into Cancer Research PA-17-295 R21   September 8, 2020 Zaria Tatalovich
240-276-6976
tatalovichzp@mail.nih.gov
Surveillance Research Not Clinical Trials
Leveraging Population-based Cancer Registry Data to Study Health Disparities PA-17-289 R01   September 8, 2020 Nadia Howlader
240-276-6891
howladern@mail.nih.gov
Surveillance Research Not Clinical Trials
Leveraging Population-based Cancer Registry Data to Study Health Disparities PA-17-288 R21   September 8, 2020 Nadia Howlader
240-276-6891
howladern@mail.nih.gov
Surveillance Research Not Clinical Trials
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-18-004 R01 Clinical Trial Optional January 8, 2020 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-18-014 R21 Clinical Trial Optional January 8, 2020 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control PAR-18-681 R01 Clinical Trial Optional October 12, 2019 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Perception and Cognition Research to Inform Cancer Image Interpretation PAR-18-640 R01 Clinical Trial Optional September 27, 2019 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Perception and Cognition Research to Inform Cancer Image Interpretation PAR-18-641 R21 Clinical Trial Optional September 27, 2019 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Neural Regulation of Cancer PAR-16-245 R01   June 28, 2019 Paige Green
240-276-6899
paige.green@nih.gov
Basic Biobehavioral and Psychological Sciences Not Clinical Trials
Neural Regulation of Cancer PAR-16-246 R21   June 28, 2019 Paige Green
240-276-6899
paige.green@nih.gov
Basic Biobehavioral and Psychological Sciences Not Clinical Trials
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control PAR-19-309 R21 Clinical Trial Optional September 8, 2022 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Health Behaviors Research Clinical Trials
Nutrition and Alcohol-Related Health Outcomes PA-17-211 R01   May 8, 2020 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Health Behaviors Research Not Clinical Trials
Nutrition and Alcohol-Related Health Outcomes NOT-CA-19-012 May 8, 2020 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Health Behaviors Research Not Clinical Trials
Time-Sensitive Obesity Policy and Program Evaluation PAR-18-854 R01   September 11, 2021 David Berrigan
240-276-6752
David.Berrigan@nih.gov

Jill Reedy
240-276-6812
reedyj@mail.nih.gov
Health Behaviors Research Not Clinical Trials
Exploratory/Developmental Clinical Research Grants in Obesity PA-18-720 R21 Clinical Trial Optional May 8, 2021 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov 
Health Behaviors Research Clinical Trials
Testing Interventions for Health-Enhancing Physical Activity PAR-18-324 R01 Clinical Trial Optional January 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Health Behaviors Research Clinical Trials
Testing Interventions for Health-Enhancing Physical Activity PAR-18-307 R21/R33 Clinical Trial Optional January 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Health Behaviors Research Clinical Trials
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness PA-18-498 R01 Clinical Trial Optional May 8, 2021 Sylvia Chou
240-276-6954
chouws@mail.nih.gov
Health Communication and Informatics Research Clinical Trials
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness PA-18-499 R21 Clinical Trial Optional May 8, 2021 Sylvia Chou
240-276-6954
chouws@mail.nih.gov
Health Communication and Informatics Research Clinical Trials
Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities PAR-19-093 R01 Clinical Trial Optional March 5, 2021 April Oh
240-276-6709
april.oh@nih.gov
Health Communication and Informatics Research Clinical Trials
Innovative Approaches to Studying Cancer Communication in the New Media Environment PAR-18-638 R01 Clinical Trial Optional June 14, 2019 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Health Communication and Informatics Research Clinical Trials
Innovative Approaches to Studying Cancer Communication in the New Media Environment PAR-18-639 R21 Clinical Trial Optional June 14, 2019 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Health Communication and Informatics Research Clinical Trials
Mechanism for Time-Sensitive Drug Abuse Research PAR-19-064 R21 Clinical Trial Optional November 9, 2021 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Tobacco Control Research Clinical Trials
Mechanism for Time-Sensitive Drug Abuse Research NOT-CA-19-015     November 9, 2021 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Tobacco Control Research Not Clinical Trials
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study PAR-19-162 R01 Clinical Trial Not Allowed September 8, 2021 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Not Clinical Trials
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study PAR-19-163 R21 Clinical Trial Not Allowed September 8, 2021 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Not Clinical Trials
Tobacco Regulatory Science RFA-OD-19-019 R01 Clinical Trial Optional February 14, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Clinical Trials
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services PAR-18-222 R01 Clinical Trial Optional November 14, 2020 Michele Bloch
240-276-6878
blochm@mail.nih.gov
Tobacco Control Research Clinical Trials
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services PAR-16-455 R01   November 14, 2020 Michele Bloch
240-276-6878
blochm@mail.nih.gov
Tobacco Control Research Not Clinical Trials
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research PAR-18-847 R01 Clinical Trial Optional June 28, 2020 For cancer-related FOA questions:
Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov

For general FOA questions:
Dionne Godette-Greer
Office of Disease Prevention (ODP)
301-480-1161
dionne.godette@nih.gov
Tobacco Control Research Clinical Trials
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research PAR-18-848 R21 Clinical Trial Optional June 28, 2020 For cancer-related FOA questions:
Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov

For general FOA questions:
Dionne Godette-Greer
Office of Disease Prevention (ODP)
301-480-1161
dionne.godette@nih.gov
Tobacco Control Research Clinical Trials
U.S. Tobacco Control Policies to Reduce Health Disparities PAR-18-675 R01 Clinical Trial Optional June 16, 2020 Bob Vollinger
240-276-6919
Bob.Vollinger@nih.gov

Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Clinical Trials
U.S. Tobacco Control Policies to Reduce Health Disparities PAR-18-674 R21 Clinical Trial Optional June 16, 2020 Bob Vollinger
240-276-6919
Bob.Vollinger@nih.gov

Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Clinical Trials
Tobacco Use and HIV in Low and Middle Income Countries PAR-18-023 R01 Clinical Trial Optional January 8, 2020 Mark Parascandola
240-276-6871
Mark.Parascandola@nih.gov
Tobacco Control Research Clinical Trials
Tobacco Use and HIV in Low and Middle Income Countries PAR-18-022 R21 Clinical Trial Optional January 8, 2020 Mark Parascandola
240-276-6871
Mark.Parascandola@nih.gov
Tobacco Control Research Clinical Trials
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes PAR-18-086 R21/R33 Clinical Trial Optional September 8, 2019 Michele Bloch
240-276-6878
blochm@mail.nih.gov
Tobacco Control Research Clinical Trials
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes PAR-18-085 R33 Clinical Trial Optional September 8, 2019 Michele Bloch
240-276-6878
blochm@mail.nih.gov
Tobacco Control Research Clinical Trials
Integrative Research on Polysubstance Abuse and Addiction PAR-18-084 R21/R33 Clinical Trial Optional September 8, 2019 Michele Bloch
240-276-6878
blochm@mail.nih.gov
Tobacco Control Research Clinical Trials

 

Go to the Archive of Funding Opportunities for information on recent funding announcements. Visit the Cancer Control Research section of this website for descriptive information on currently funded grants in this area.